{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:00:58Z","timestamp":1784232058376,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00520-023-07800-9","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T03:31:18Z","timestamp":1685158278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Financial toxicity experienced by patients with breast cancer-related lymphedema: a systematic review"],"prefix":"10.1007","volume":"31","author":[{"given":"Jingru","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aomei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmin","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"issue":"1","key":"7800_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"7800_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B (2022) Breast cancer: an up-to-date review and future perspectives. Cancer Commun 42(10):913\u2013936. https:\/\/doi.org\/10.1002\/cac2.12358","journal-title":"Cancer Commun"},{"key":"7800_CR3","doi-asserted-by":"publisher","first-page":"CD003475","DOI":"10.1002\/14651858.CD003475.pub2","volume":"5","author":"J Ezzo","year":"2015","unstructured":"Ezzo J, Manheimer E, McNeely ML et al (2015) Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev 5:CD003475. Published 2015 May 21. https:\/\/doi.org\/10.1002\/14651858.CD003475.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"7800_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12609-017-0237-8","volume":"9","author":"HE Sayegh","year":"2017","unstructured":"Sayegh HE, Asdourian MS, Swaroop MN et al (2017) Diagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: past, present, and future directions. Curr Breast Cancer Rep 9(2):111\u2013121. https:\/\/doi.org\/10.1007\/s12609-017-0237-8","journal-title":"Curr Breast Cancer Rep"},{"issue":"6","key":"7800_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B et al (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"7800_CR6","doi-asserted-by":"publisher","unstructured":"Boeer B, Seller A, Schoenfisch B et al (2022) The impact of rehabilitation sport on breast cancer-related lymphoedema and quality of life [published online ahead of print, 2022 Jul 26]. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-022-06609-x","DOI":"10.1007\/s00404-022-06609-x"},{"key":"7800_CR7","doi-asserted-by":"publisher","unstructured":"Mete Civelek G, Akinci MG, Dalyan M (2022) Evaluation of sleep quality, depression, and quality of life in patients with breast cancer related lymphedema [published online ahead of print, 2022 Sep 29]. Lymphat Res Biol. https:\/\/doi.org\/10.1089\/lrb.2022.0031","DOI":"10.1089\/lrb.2022.0031"},{"issue":"1","key":"7800_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.25082\/CCR.2020.01.004","volume":"2","author":"SS Coughlin","year":"2020","unstructured":"Coughlin SS, Ayyala DN, Tingen MS, Cortes JE (2020) Financial distress among breast cancer survivors. Curr Cancer Rep 2(1):48\u201353. https:\/\/doi.org\/10.25082\/CCR.2020.01.004","journal-title":"Curr Cancer Rep"},{"issue":"11","key":"7800_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/cncr.32012","volume":"125","author":"LT Dean","year":"2019","unstructured":"Dean LT, Moss SL, Rollinson SI, Frasso Jaramillo L, Paxton RJ, Owczarzak JT (2019) Patient recommendations for reducing long-lasting economic burden after breast cancer. Cancer 125(11):1929\u20131940. https:\/\/doi.org\/10.1002\/cncr.32012","journal-title":"Cancer"},{"issue":"11","key":"7800_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","volume":"11","author":"HR Abrams","year":"2021","unstructured":"Abrams HR, Durbin S, Huang CX et al (2021) Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med 11(11):2043\u20132054. https:\/\/doi.org\/10.1093\/tbm\/ibab091","journal-title":"Transl Behav Med"},{"issue":"2","key":"7800_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/COC.0000000000000355","volume":"41","author":"TD Smile","year":"2018","unstructured":"Smile TD, Tendulkar R, Schwarz G et al (2018) A review of treatment for breast cancer-related lymphedema: paradigms for clinical practice. Am J Clin Oncol 41(2):178\u2013190. https:\/\/doi.org\/10.1097\/COC.0000000000000355","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"7800_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/jso.27054","volume":"126","author":"MH Cheng","year":"2022","unstructured":"Cheng MH, Ho OA, Tsai TJ, Lin YL, Kuo CF (2022) Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality. J Surg Oncol 126(7):1162\u20131168. https:\/\/doi.org\/10.1002\/jso.27054","journal-title":"J Surg Oncol"},{"issue":"4","key":"7800_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamaoncol.2020.7891","volume":"7","author":"ML Roberson","year":"2021","unstructured":"Roberson ML, Strassle PD, Fasehun LO, Erim DO, Deune EG, Ogunleye AA (2021) Financial burden of lymphedema hospitalizations in the United States. JAMA Oncol 7(4):630\u2013632. https:\/\/doi.org\/10.1001\/jamaoncol.2020.7891","journal-title":"JAMA Oncol"},{"issue":"2","key":"7800_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00520-019-05101-8","volume":"28","author":"T De Vrieze","year":"2020","unstructured":"De Vrieze T, Nevelsteen I, Thomis S et al (2020) What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Support Care Cancer 28(2):439\u2013449. https:\/\/doi.org\/10.1007\/s00520-019-05101-8","journal-title":"Support Care Cancer"},{"issue":"5","key":"7800_CR15","doi-asserted-by":"publisher","first-page":"e0216386","DOI":"10.1371\/journal.pone.0216386","volume":"14","author":"G Mercier","year":"2019","unstructured":"Mercier G, Pastor J, Cl\u00e9ment V, Rodts U, Moffat C, Qu\u00e9r\u00e9 I (2019) Out-of-pocket payments, vertical equity and unmet medical needs in France: a national multicenter prospective study on lymphedema. PLoS One 14(5):e0216386. https:\/\/doi.org\/10.1371\/journal.pone.0216386","journal-title":"PLoS One"},{"issue":"10","key":"7800_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/qjmed\/hcg126","volume":"96","author":"CJ Moffatt","year":"2003","unstructured":"Moffatt CJ, Franks PJ, Doherty DC et al (2003) Lymphoedema: an underestimated health problem. QJM 96(10):731\u2013738. https:\/\/doi.org\/10.1093\/qjmed\/hcg126","journal-title":"QJM"},{"issue":"2","key":"7800_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21443","volume":"68","author":"PM Carrera","year":"2018","unstructured":"Carrera PM, Kantarjian HM, Blinder VS (2018) The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin 68(2):153\u2013165. https:\/\/doi.org\/10.3322\/caac.21443","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"7800_CR18","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.3390\/ijerph18052422","volume":"18","author":"A Bygrave","year":"2021","unstructured":"Bygrave A, Whittaker K, Paul C, Fradgley EA, Varlow M, Aranda S (2021) Australian experiences of out-of-pocket costs and financial burden following a cancer diagnosis: a systematic review. Int J Environ Res Public Health 18(5):2422. https:\/\/doi.org\/10.3390\/ijerph18052422","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"7800_CR19","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.14442","volume":"31","author":"M Gutknecht","year":"2017","unstructured":"Gutknecht M, Herberger K, Klose K, Purwins S, Dietz D, Blome C, Augustin M (2017) Cost-of-illness of patients with lymphoedema. J Eur Acad Dermatol Venereol 31(11):1930\u20131935. https:\/\/doi.org\/10.1111\/jdv.14442","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7800_CR20","volume-title":"Joanna Briggs Institute reviewers' manual","author":"The Joanna Briggs Institute","year":"2016","unstructured":"The Joanna Briggs Institute (2016) Joanna Briggs Institute reviewers' manual. The Joanna Briggs Institute, Austrilia"},{"issue":"3","key":"7800_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/jep.12884","volume":"24","author":"QN Hong","year":"2018","unstructured":"Hong QN, Gonzalez-Reyes A, Pluye P (2018) Improving the usefulness of a tool for appraising the quality of qualitative, quantitative and mixed methods studies, the Mixed Methods Appraisal Tool (MMAT). J Eval Clin Pract 24(3):459\u2013467. https:\/\/doi.org\/10.1111\/jep.12884","journal-title":"J Eval Clin Pract"},{"issue":"12","key":"7800_CR22","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1200\/JCO.2008.18.3517","volume":"27","author":"YC Shih","year":"2009","unstructured":"Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12):2007\u20132014. https:\/\/doi.org\/10.1200\/JCO.2008.18.3517","journal-title":"J Clin Oncol"},{"issue":"1","key":"7800_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2015.06.015","volume":"211","author":"MN Basta","year":"2016","unstructured":"Basta MN, Fox JP, Kanchwala SK et al (2016) Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg 211(1):133\u2013141. https:\/\/doi.org\/10.1016\/j.amjsurg.2015.06.015","journal-title":"Am J Surg"},{"issue":"6","key":"7800_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/pon.4239","volume":"26","author":"J Boyages","year":"2017","unstructured":"Boyages J, Xu Y, Kalfa S et al (2017) Financial cost of lymphedema borne by women with breast cancer. Psychooncology 26(6):849\u2013855. https:\/\/doi.org\/10.1002\/pon.4239","journal-title":"Psychooncology"},{"issue":"5","key":"7800_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","volume":"27","author":"LT Dean","year":"2019","unstructured":"Dean LT, Moss SL, Ransome Y et al (2019) \u201cIt still affects our economic situation\u201d: long-term economic burden of breast cancer and lymphedema. Support Care Cancer 27(5):1697\u20131708. https:\/\/doi.org\/10.1007\/s00520-018-4418-4","journal-title":"Support Care Cancer"},{"issue":"5","key":"7800_CR26","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s11764-019-00799-1","volume":"13","author":"LT Dean","year":"2019","unstructured":"Dean LT, Ransome Y, Frasso-Jaramillo L et al (2019) Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv 13(5):804\u2013814. https:\/\/doi.org\/10.1007\/s11764-019-00799-1","journal-title":"J Cancer Surviv"},{"issue":"7","key":"7800_CR27","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s00520-020-05890-3","volume":"29","author":"T De Vrieze","year":"2021","unstructured":"De Vrieze T, Gebruers N, Nevelsteen I et al (2021) Breast cancer-related lymphedema and its treatment: how big is the financial impact? Support Care Cancer 29(7):3801\u20133813. https:\/\/doi.org\/10.1007\/s00520-020-05890-3","journal-title":"Support Care Cancer"},{"issue":"2","key":"7800_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.22359\/cswhi_12_2_06","volume":"12","author":"K Pitr","year":"2021","unstructured":"Pitr K (2021) Economic and social aspects of secondary lymphedema following treatment of breast cancer. CSWHI 12(2):35\u201338. https:\/\/doi.org\/10.22359\/cswhi_12_2_06","journal-title":"CSWHI"},{"issue":"76","key":"7800_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13690-018-0285-1","volume":"30","author":"W Hens","year":"2018","unstructured":"Hens W, Vissers D, Annemans L, Gielen J, Van Gaal L, Taeymans J, Verhaeghe N (2018) Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region: a cost-of-illness analysis. Arch Public Health 30(76):42. https:\/\/doi.org\/10.1186\/s13690-018-0285-1","journal-title":"Arch Public Health"},{"key":"7800_CR30","doi-asserted-by":"publisher","first-page":"e2958","DOI":"10.1590\/1518-8345.2258.2958","volume":"25","author":"RR Villar","year":"2017","unstructured":"Villar RR, Fern\u00e1ndez SP, Garea CC, Pillado MTS, Barreiro VB, Mart\u00edn CG (2017) Quality of life and anxiety in women with breast cancer before and after treatment. Rev Lat Am Enfermagem 25:e2958. Published 2017 Dec 21. https:\/\/doi.org\/10.1590\/1518-8345.2258.2958","journal-title":"Rev Lat Am Enfermagem"},{"issue":"5","key":"7800_CR31","first-page":"1735","volume":"26","author":"I Kalemikerakis","year":"2021","unstructured":"Kalemikerakis I, Evaggelakou A, Kavga A, Vastardi M, Konstantinidis T, Govina O (2021) Diagnosis, treatment and quality of life in patients with cancer-related lymphedema. J BUON 26(5):1735\u20131741","journal-title":"J BUON"},{"issue":"6","key":"7800_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/pon.5361","volume":"29","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Xing W, Zhang X, Hu Y, So WKW (2020) Cancer survivors\u2019 experiences with financial toxicity: a systematic review and meta-synthesis of qualitative studies. Psychooncology 29(6):945\u2013959. https:\/\/doi.org\/10.1002\/pon.5361","journal-title":"Psychooncology"},{"issue":"9","key":"7800_CR33","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s00520-022-07044-z","volume":"30","author":"A Donkor","year":"2022","unstructured":"Donkor A, Atuwo-Ampoh VD, Yakanu F, Torgbenu E, Ameyaw EK, Kitson-Mills D, Vanderpuye V, Kyei KA, Anim-Sampong S, Khader O, Khader J (2022) Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis. Support Care Cancer 30(9):7159\u20137190. https:\/\/doi.org\/10.1007\/s00520-022-07044-z","journal-title":"Support Care Cancer"},{"issue":"12","key":"7800_CR34","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/S1470-2045(21)00468-X","volume":"22","author":"JM Boby","year":"2021","unstructured":"Boby JM, Rajappa S, Mathew A (2021) Financial toxicity in cancer care in India: a systematic review. Lancet Oncol 22(12):e541\u2013e549. https:\/\/doi.org\/10.1016\/S1470-2045(21)00468-X","journal-title":"Lancet Oncol"},{"issue":"1","key":"7800_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13561-016-0117-3","volume":"6","author":"R Weiss","year":"2016","unstructured":"Weiss R (2016) Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia. Health Econ Rev 6(1):42. https:\/\/doi.org\/10.1186\/s13561-016-0117-3 Epub 2016 Sep 2. Erratum in: Health Econ Rev. 2016 Dec;6(1):47. PMID: 27590738; PMCID: PMC5010541","journal-title":"Health Econ Rev"},{"issue":"1","key":"7800_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jvn.2022.01.002","volume":"40","author":"E Duygu Yildiz","year":"2022","unstructured":"Duygu Yildiz E, Bakar Y, Keser I (2022) What do lymphedema patients expect from a treatment and what do they achieve? A descriptive study. J Vasc Nurs 40(1):59\u201365. https:\/\/doi.org\/10.1016\/j.jvn.2022.01.002","journal-title":"J Vasc Nurs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07800-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:09:30Z","timestamp":1686388170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07800-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7800"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07800-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"23 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As this is a systematic review reporting on existing data, ethics approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"354"}}